ProPhase Labs shares are trading lower by 50% during Friday's session. The company announced a 4.17 million share offering at ...

ThinkEquity is acting as sole book-running manager for the offering.

On Friday, Lineage Cell Therapeutics Inc (LCTX) stock saw a modest uptick, ending the day at $0.91 which represents a slight increase of $0.07 or 8.33% from the prior close of $0.84. The stock opened ...

GARDEN CITY, NY - ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and diagnostics company, announced today its financial outlook for 2025, projecting substantial revenue and pre-tax ...

Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 GARDEN CITY, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs ...